Posts in tag

PPIs


ASMI has issued a statement saying consumers can be confident in the safety profile of OTC proton pump inhibitors A study published in Gut has shown that people who regularly …

Debbie Rigby takes a look at the latest in research news  We have had a gutful: The need for deprescribing proton pump inhibitors Times series analysis of PBS and RPBS …

The Schedule 3 entry for proton-pump inhibitor esomeprazole is set to be deleted from 1 February 2018 The TGA delegate has made an interim decision to downschedule the PPI to Pharmacy …

Debbie Rigby takes a look at the latest in research news Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL …

Debbie Rigby takes a look at the latest in research news Role of Direct Oral Anticoagulants in the Management of Anticoagulation This article reviews the roles of dabigatran, rivaroxaban, apixaban, …

ASMI has moved to reassure patients after a study linked PPIs to a higher risk of death The study’s authors have suggested it may be time to restrict the indications …

Debbie Rigby rounds up the latest in research news Benzodiazepines, Z-drugs and the risk of hip fracture There is strong evidence that both BNZ and Z-drugs are associated with an …

Debbie Rigby takes a look at the latest in research news Acid suppression medications and bacterial gastroenteritis A Scottish cohort study has use of proton pump inhibitors (PPIs) and H2 …

Users of acid suppression drugs should be vigilant about food hygiene due to increased risk of bacterial gastroenteritis Researchers in Scotland have found a positive association between use of acid …

PPI use is increasing, writes Ben Basger—but what is its role long term? Do you think that when doctors decide to block the production of stomach acid by using a …

Debbie Rigby takes a look at the latest research news Manufacturer failed to disclose faulty device in rivaroxaban trial An investigation by The BMJ finds that companies were aware of …

NPS MedicineWise has launched a new learning program and health professional tools on the use of proton pump inhibitors in the treatment of uncomplicated gastro-oesophageal reflux disease. The program focuses …